{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T16:49:03Z","timestamp":1772470143710,"version":"3.50.1"},"reference-count":72,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,6,16]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Translocations between PD-L1 and the IGH locus represent a genetic mechanism of PD-L1 overexpression in DLBCL. Genetic alterations in the PD-L1\/PDL-2 locus are mainly associated with the non-GCB subtype of DLBCL.<\/jats:p>","DOI":"10.1182\/blood-2015-12-686550","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T03:24:09Z","timestamp":1459394649000},"page":"3026-3034","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":176,"title":["Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas"],"prefix":"10.1182","volume":"127","author":[{"given":"Konstantinos","family":"Georgiou","sequence":"first","affiliation":[{"name":"Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden;"}]},{"given":"Longyun","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden;"},{"name":"BGI-Shenzhen, Shenzhen, China;"}]},{"given":"Mattias","family":"Berglund","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Nutrition, Karolinska Institutet, Solna, Sweden;"}]},{"given":"Weicheng","family":"Ren","sequence":"additional","affiliation":[{"name":"Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden;"}]},{"given":"Noel F. C. C.","family":"de Miranda","sequence":"additional","affiliation":[{"name":"Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands;"}]},{"given":"Susana","family":"Lisboa","sequence":"additional","affiliation":[{"name":"Department of Genetics, Portuguese Oncology Institute, and Abel Salazar Biomedical Sciences Institute, Porto University, Porto, Portugal;"}]},{"given":"Marco","family":"Fangazio","sequence":"additional","affiliation":[{"name":"Institute for Cancer Genetics, Columbia University, New York, NY;"}]},{"given":"Shida","family":"Zhu","sequence":"additional","affiliation":[{"name":"BGI-Shenzhen, Shenzhen, China;"}]},{"given":"Yong","family":"Hou","sequence":"additional","affiliation":[{"name":"BGI-Shenzhen, Shenzhen, China;"}]},{"given":"Kui","family":"Wu","sequence":"additional","affiliation":[{"name":"BGI-Shenzhen, Shenzhen, China;"}]},{"given":"Wenfeng","family":"Fang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China and Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China;"}]},{"given":"Xianhuo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China;"}]},{"given":"Bin","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China;"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China and Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China;"}]},{"given":"Yixin","family":"Zeng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China and Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China;"}]},{"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University, New York, NY;"}]},{"given":"Magnus","family":"Nordenskj\u00f6ld","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Solna, Sweden; and"}]},{"given":"Christer","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Rudbecklaboratoriet, Uppsala University, Uppsala, Sweden"}]},{"given":"Gunilla","family":"Enblad","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Rudbecklaboratoriet, Uppsala University, Uppsala, Sweden"}]},{"given":"Riccardo","family":"Dalla-Favera","sequence":"additional","affiliation":[{"name":"Institute for Cancer Genetics, Columbia University, New York, NY;"}]},{"given":"Huilai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China;"}]},{"given":"Manuel R.","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Department of Genetics, Portuguese Oncology Institute, and Abel Salazar Biomedical Sciences Institute, Porto University, Porto, Portugal;"}]},{"given":"Laura","family":"Pasqualucci","sequence":"additional","affiliation":[{"name":"Institute for Cancer Genetics, Columbia University, New York, NY;"}]},{"given":"Roujun","family":"Peng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China and Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China;"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1990-8804","authenticated-orcid":false,"given":"Qiang","family":"Pan-Hammarstr\u00f6m","sequence":"additional","affiliation":[{"name":"Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden;"}]}],"member":"234","reference":[{"issue":"3","key":"2019111904234555900_B1","first-page":"83","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview.","volume":"102","author":"Sabattini","year":"2010","journal-title":"Pathologica"},{"issue":"6769","key":"2019111904234555900_B2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"22","key":"2019111904234555900_B3","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas.","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111904234555900_B4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111904234555900_B5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"Lancet Oncol"},{"issue":"1","key":"2019111904234555900_B6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrclinonc.2013.197","article-title":"Diffuse large B-cell lymphoma-treatment approaches in the molecular era.","volume":"11","author":"Roschewski","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"7337","key":"2019111904234555900_B7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma.","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"issue":"10","key":"2019111904234555900_B8","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"2019111904234555900_B9","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1182\/blood-2013-12-546309","article-title":"Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.","volume":"124","author":"de Miranda","year":"2014","journal-title":"Blood"},{"issue":"7360","key":"2019111904234555900_B10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"4","key":"2019111904234555900_B11","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma.","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019111904234555900_B12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"issue":"21","key":"2019111904234555900_B13","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1182\/blood-2012-02-414441","article-title":"TBL1XR1\/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma.","volume":"119","author":"Scott","year":"2012","journal-title":"Blood"},{"issue":"7","key":"2019111904234555900_B14","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","article-title":"Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.","volume":"122","author":"Morin","year":"2013","journal-title":"Blood"},{"issue":"7338","key":"2019111904234555900_B15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"issue":"11","key":"2019111904234555900_B16","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1038\/sj.leu.2404856","article-title":"Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.","volume":"21","author":"Iqbal","year":"2007","journal-title":"Leukemia"},{"issue":"4587","key":"2019111904234555900_B17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1126\/science.6401867","article-title":"Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas.","volume":"219","author":"Dalla-Favera","year":"1983","journal-title":"Science"},{"issue":"5134","key":"2019111904234555900_B18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1126\/science.8235596","article-title":"Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma.","volume":"262","author":"Ye","year":"1993","journal-title":"Science"},{"issue":"40","key":"2019111904234555900_B19","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1038\/sj.onc.1204640","article-title":"Mechanisms of chromosomal translocations in B cell lymphomas.","volume":"20","author":"K\u00fcppers","year":"2001","journal-title":"Oncogene"},{"issue":"6","key":"2019111904234555900_B20","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cell.2008.09.062","article-title":"AID is required for the chromosomal breaks in c-myc that lead to c-myc\/IgH translocations.","volume":"135","author":"Robbiani","year":"2008","journal-title":"Cell"},{"key":"2019111904234555900_B21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-pathol-020712-164004","article-title":"Chromosome translocation, B cell lymphoma, and activation-induced cytidine deaminase.","volume":"8","author":"Robbiani","year":"2013","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"2019111904234555900_B22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","article-title":"Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.","volume":"102","author":"Muramatsu","year":"2000","journal-title":"Cell"},{"issue":"6893","key":"2019111904234555900_B23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature00862","article-title":"AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification.","volume":"418","author":"Petersen-Mahrt","year":"2002","journal-title":"Nature"},{"issue":"1517","key":"2019111904234555900_B24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1098\/rstb.2008.0196","article-title":"Non-homologous end joining in class switch recombination: the beginning of the end.","volume":"364","author":"Kotnis","year":"2009","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"9","key":"2019111904234555900_B25","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1084\/jem.20122842","article-title":"DNA repair genes are selectively mutated in diffuse large B cell lymphomas.","volume":"210","author":"de Miranda","year":"2013","journal-title":"J Exp Med"},{"issue":"3","key":"2019111904234555900_B26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.coi.2007.04.012","article-title":"PD-1 and its ligands in T-cell immunity.","volume":"19","author":"Keir","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"2019111904234555900_B27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity.","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"2019111904234555900_B28","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1073\/pnas.0611533104","article-title":"Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer.","volume":"104","author":"Hamanishi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2019111904234555900_B29","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/cncr.25747","article-title":"Overall survival and PD-L1 expression in metastasized malignant melanoma.","volume":"117","author":"Gadiot","year":"2011","journal-title":"Cancer"},{"issue":"15","key":"2019111904234555900_B30","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1158\/1078-0432.CCR-04-0428","article-title":"B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.","volume":"10","author":"Konishi","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"26","key":"2019111904234555900_B31","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111904234555900_B32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma.","volume":"372","author":"Ansell","year":"2015","journal-title":"N Engl J Med"},{"issue":"13","key":"2019111904234555900_B33","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma.","volume":"123","author":"Twa","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2019111904234555900_B34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/path.4522","article-title":"Recurrent genomic rearrangements in primary testicular lymphoma.","volume":"236","author":"Twa","year":"2015","journal-title":"J Pathol"},{"issue":"7","key":"2019111904234555900_B35","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","article-title":"Targetable genetic features of primary testicular and primary central nervous system lymphomas.","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"issue":"13","key":"2019111904234555900_B36","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1158\/1078-0432.CCR-10-2660","article-title":"Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells.","volume":"17","author":"Andorsky","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"19","key":"2019111904234555900_B37","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood-2015-02-629600","article-title":"Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma.","volume":"126","author":"Kiyasu","year":"2015","journal-title":"Blood"},{"issue":"9","key":"2019111904234555900_B38","doi-asserted-by":"crossref","first-page":"e0136476","DOI":"10.1371\/journal.pone.0136476","article-title":"PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro.","volume":"10","author":"Quan","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"2019111904234555900_B39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"17","key":"2019111904234555900_B40","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.","volume":"100","author":"Wright","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2019111904234555900_B41","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.cell.2014.11.013","article-title":"B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity.","volume":"159","author":"Qian","year":"2014","journal-title":"Cell"},{"issue":"1","key":"2019111904234555900_B42","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajhg.2015.05.005","article-title":"A 3.4-kb copy-number deletion near EPAS1 is significantly enriched in high-altitude Tibetans but absent from the Denisovan sequence.","volume":"97","author":"Lou","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"4.21","key":"2019111904234555900_B43","first-page":"1","article-title":"Next-generation sequencing RNA-seq library construction.","volume":"106","author":"Podnar","year":"2014","journal-title":"Curr Protoc Mol Biol"},{"issue":"2","key":"2019111904234555900_B44","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/gb-2013-14-2-r12","article-title":"SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data.","volume":"14","author":"Jia","year":"2013","journal-title":"Genome Biol"},{"issue":"8","key":"2019111904234555900_B45","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","article-title":"Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.","volume":"123","author":"Scott","year":"2014","journal-title":"Blood"},{"issue":"13","key":"2019111904234555900_B46","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1158\/1078-0432.CCR-05-1977","article-title":"8q gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects.","volume":"12","author":"Ribeiro","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2019111904234555900_B47","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.4049\/jimmunol.137.7.2299","article-title":"Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.","volume":"137","author":"Stam","year":"1986","journal-title":"J Immunol"},{"issue":"4","key":"2019111904234555900_B48","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.4049\/jimmunol.171.4.1918","article-title":"Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide.","volume":"171","author":"Perosa","year":"2003","journal-title":"J Immunol"},{"issue":"3","key":"2019111904234555900_B49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0161-5890(98)00026-1","article-title":"Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents.","volume":"35","author":"Sernee","year":"1998","journal-title":"Mol Immunol"},{"issue":"8","key":"2019111904234555900_B50","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1073\/pnas.0712278105","article-title":"The PD-1\/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors.","volume":"105","author":"Lin","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2019111904234555900_B51","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/70932","article-title":"B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.","volume":"5","author":"Dong","year":"1999","journal-title":"Nat Med"},{"issue":"6844","key":"2019111904234555900_B52","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"issue":"6","key":"2019111904234555900_B53","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of \u03b22-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma.","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"issue":"9","key":"2019111904234555900_B54","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.4049\/jimmunol.139.9.3132","article-title":"The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit.","volume":"139","author":"G\u00fcssow","year":"1987","journal-title":"J Immunol"},{"issue":"3","key":"2019111904234555900_B55","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nri3391","article-title":"Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates.","volume":"13","author":"Shechter","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"49","key":"2019111904234555900_B56","doi-asserted-by":"crossref","first-page":"17174","DOI":"10.1073\/pnas.0406351101","article-title":"Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.","volume":"101","author":"Thompson","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2019111904234555900_B57","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/cncr.24899","article-title":"Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma.","volume":"116","author":"Hino","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"2019111904234555900_B58","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1158\/1078-0432.CCR-08-1608","article-title":"Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma.","volume":"15","author":"Gao","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"7528","key":"2019111904234555900_B59","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance.","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"issue":"7528","key":"2019111904234555900_B60","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature"},{"issue":"7385","key":"2019111904234555900_B61","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature10755","article-title":"Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.","volume":"482","author":"Matsushita","year":"2012","journal-title":"Nature"},{"issue":"12","key":"2019111904234555900_B62","doi-asserted-by":"crossref","first-page":"djv279","DOI":"10.1093\/jnci\/djv279","article-title":"Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.","volume":"107","author":"Sampson","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2019111904234555900_B63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccell.2015.06.012","article-title":"Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy.","volume":"28","author":"Kelderman","year":"2015","journal-title":"Cancer Cell"},{"issue":"8","key":"2019111904234555900_B64","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00251-008-0303-5","article-title":"Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy.","volume":"60","author":"Carretero","year":"2008","journal-title":"Immunogenetics"},{"issue":"1","key":"2019111904234555900_B65","first-page":"37","article-title":"Absence of HLA class I expression by Reed-Sternberg cells.","volume":"145","author":"Poppema","year":"1994","journal-title":"Am J Pathol"},{"issue":"7","key":"2019111904234555900_B66","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nri2993","article-title":"The golden anniversary of the thymus.","volume":"11","author":"Miller","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"2019111904234555900_B67","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1182\/blood-2003-07-2365","article-title":"Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.","volume":"103","author":"Rimsza","year":"2004","journal-title":"Blood"},{"issue":"13","key":"2019111904234555900_B68","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies.","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2019111904234555900_B69","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity.","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"issue":"17","key":"2019111904234555900_B70","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111904234555900_B71","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.humpath.2012.10.026","article-title":"MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.","volume":"44","author":"Choi","year":"2013","journal-title":"Hum Pathol"},{"issue":"12","key":"2019111904234555900_B72","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood-2011-10-388538","article-title":"Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation.","volume":"119","author":"Gupta","year":"2012","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/24\/3026\/1393975\/3026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/24\/3026\/1393975\/3026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T12:00:30Z","timestamp":1692273630000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/127\/24\/3026\/35419\/Genetic-basis-of-PDL1-overexpression-in-diffuse"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,16]]},"references-count":72,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2016,6,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-12-686550","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,16]]}}}